Andrew Witty


Sir Andrew Witty
Witty pada 22 Oktober 2015 di Chatham House
Lahir22 Agustus 1964 (umur 61)
AlmamaterUniversitas Nottingham
PekerjaanCEO, Optum
PendahuluJean-Pierre Garnier
PenggantiEmma Walmsley
Suami/istriCaroline M. Witty (née Hall)
Anak2 [1]
X: wittyandrewww Modifica els identificadors a Wikidata

Sir Andrew Philip Witty (lahir 22 Agustus 1964)[1] adalah seorang eksekutif bisnis asal Inggris, yang menjadi kepala jabatan eksekutif (CEO) GlaxoSmithKline antara 2008 dan 2017. Witty digantikan oleh Emma Walmsley pada 1 April 2017.[2][3] Ia dulunya menjabat sebagai Kanselir Universitas Nottingham.[4]

Referensi

  1. ^ a b Davidson, Andrew (26 July 2009). "The Andrew Davidson Interview: Andrew Witty". The Sunday Times. London. Diakses tanggal 11 December 2010.
  2. ^ Kollewe, Julia (17 March 2016). "GSK chief Andrew Witty to leave drugmaker". The Guardian. Diakses tanggal 17 March 2016.
  3. ^ "Emma Walmsley". GSK. Diarsipkan dari asli tanggal 2020-03-16. Diakses tanggal 3 April 2017.
  4. ^ "Chancellor". University of Nottingham. Diakses tanggal 13 January 2020.

Pranala luar

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.